Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Healthtrust
McKinsey
Julphar
Harvard Business School
Moodys
Teva
Accenture
Chinese Patent Office

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020259

« Back to Dashboard

NDA 020259 describes MEPRON, which is a drug marketed by Glaxosmithkline Llc and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the MEPRON profile page.

The generic ingredient in MEPRON is atovaquone. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atovaquone profile page.
Summary for 020259
Tradename:MEPRON
Applicant:Glaxosmithkline Llc
Ingredient:atovaquone
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020259

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Nov 25, 1992TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Citi
Colorcon
Johnson and Johnson
US Department of Justice
Fish and Richardson
Baxter
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot